Research & KnowledgeEvent: September 3, 2026
Cerenome is actively recruiting pediatric brain cancer patients for its ReSPECT-PBC U.S. Phase 1 clinical trial.
Published
Signal category
Research & Knowledge
Quote
“Cerenome’s ReSPECT-PBC U.S. Phase 1 #ClinicalTrial is actively recruiting pediatric #braincancer patients”
— Cerenome team
Company
Cerenome
Think it solvable.
- Industry
- Biotechnology Research
- Location
- Houston, US
- Company size
- 31 employees
Cerenome (Nasdaq: CNSY) connects precision diagnostics, targeted therapeutics, and patient data into an integrated central nervous system (CNS) oncology platform designed to improve how CNS cancers are detected, treated, and understood. (Previously Plus Therapeutics)
Founded 2019